Epilepsy is very common in tuberous sclerosis complex and occurs in 80 to 90% of affected individuals during their lifetime. Onset usually occurs during childhood, and up to one third of children ...

J Child Neurol. 2004;19(9):680-686. Alternative treatments to anticonvulsant medications should be considered in patients with tuberous sclerosis complex when seizures cannot be effectively ...

This important study describes a combination of in vitro and in vivo results implicating Dyrk1a in the regulation of mTOR. Strengths include the combination of cell and whole-animal (Drosophila) based ...

If you've been diagnosed with multiple sclerosis (MS), it's time to start exploring treatment options. You've got a lot of them, everything from disease-modifying therapies and drugs that help manage ...

Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in ...

The event will raise funds to further tuberous sclerosis complex (TSC) research and expand support programs for individuals and families affected by the disease. Formed in 1974 by four mothers in ...

The event will raise funds to further tuberous sclerosis complex (TSC) research and expand support programs for individuals and families affected by the disease. Formed in 1974 by four mothers ...

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Dr. Dennis Bourdette, founder of the MS Center, and Dr. Vijayshree Yadav, director, bring excellence in both care and research together. The OHSU Multiple Sclerosis Center is one of the top programs ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...